Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.370
-0.020 (-0.84%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aerovate Therapeutics Market Cap
Aerovate Therapeutics has a market cap or net worth of $68.43 million as of February 21, 2025. Its market cap has decreased by -87.62% in one year.
Market Cap
68.43M
Enterprise Value
-19.76M
1-Year Change
-87.62%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has decreased from $323.51M to $68.43M, a decrease of -78.85%. That is a compound annual growth rate of -34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 68.43M | -10.57% |
| Dec 31, 2024 | 76.52M | -87.78% |
| Dec 29, 2023 | 626.15M | -13.15% |
| Dec 30, 2022 | 720.93M | 150.50% |
| Dec 31, 2021 | 287.80M | -11.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |